CD133 mRNA Transfected Dendritic Cells Induces a Coordinated Cytotoxic and Helper T Cell Responses against Breast Cancer Stem Cells.

Researchers hypothesized that by creating an MHC independent vaccination, they would give rise to a sustained immune response against CD133 in triple negative breast carcinomas.